68Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer
暂无分享,去创建一个
A. Azad | A. Coleman | S. Appu | E. Kwan | E. Segelov | S. Ramdave | C. Gan | J. Kourambas | G. Soo | A. Davies | J. Bradley | S. Donnellan | N. Redgrave | S. Williams | M. Foo